Clinical contribution of the collateral circulation to myocardial protection

Robert D Smith1, Charles D J Ilsley

  • 1Department of Cardiology, Harefield Hospital, Royal Brompton and Harefield NHS Trust, Harefield, Middlesex, UK.

Coronary Artery Disease
|October 20, 2004
PubMed

Insights

Coronary collateral channels show a protective effect in myocardial infarction patients, irrespective of reperfusion therapy or preformed collaterals. Their role in collateral development is still debated.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Cardiology
  • Ischemic Heart Disease

Background:

  • Coronary collateral channels (CCC) play a role in myocardial infarction (MI) outcomes.
  • The protective potential of CCC is increasingly recognized in cardiovascular research.
  • Understanding CCC mechanisms is crucial for improving MI treatment.

Purpose of the Study:

  • To review and synthesize the clinical evidence for the benefit of coronary collateral channels in patients with myocardial infarction.
  • To evaluate the impact of reperfusion therapy and preformed collaterals on the protective effect of CCC.
  • To discuss the controversial role of pre-infarction angina in stimulating collateral development.

Main Methods:

  • Review of existing clinical studies and data on coronary collateral channels and myocardial infarction.
  • Analysis of patient outcomes in relation to the presence and function of CCC.
  • Examination of factors influencing collateral development, such as pre-infarction angina.

Main Results:

  • Clinical evidence suggests a protective effect of CCC in patients experiencing myocardial infarction.
  • This protective benefit appears consistent regardless of whether patients receive reperfusion therapy.
  • The presence of preformed collaterals is associated with a beneficial effect, though their origin is not always clear.

Conclusions:

  • Coronary collateral channels offer a significant protective benefit to patients suffering myocardial infarction.
  • The benefit of CCC is evident irrespective of reperfusion status or whether collaterals were pre-existing.
  • Further research is needed to clarify the role of pre-infarction angina in CCC formation and its clinical implications.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Physiology of the Heart: The Cardiac Cycle01:18

Physiology of the Heart: The Cardiac Cycle

The cardiac cycle describes the events from one heartbeat to the next. It includes three main phases: diastole, atrial systole, and ventricular systole, all driven by changes in chamber pressures and the function of heart valves.
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...